WHO launches Health Alert on WhatsApp to debunk COVID-19 myths

Google has indexed invite links to private WhatsApp group chats, meaning anyone can join various private chat groups (including several porn-sharing groups) with a simple search.

According to a report in Motherboard, invitations to WhatsApp group chats were being indexed by Google.

The team found private groups using specific Google searches and even joined a group intended for NGOs accredited by the UN and had access to all the participants and their phone numbers.

Journalist Jordan Wildon said on Twitter that he discovered that WhatsApp's "Invite to Group Link" feature lets Google index groups, making them available across the internet since the links are being shared outside of WhatsApp's secure private messaging service.

"Your WhatsApp groups may not be as secure as you think they are," Wildon tweeted on Friday, adding that using particular Google searches, people can discover links to the chats.

According to app reverse-engineer Jane Wong, Google has around 470,000 results for a simple search of "chat.whatsapp.com", part of the URL that makes up invites to WhatsApp groups.

WhatsApp spokesperson Alison Bonny said: "Like all content that is shared in searchable public channels, invite links that are posted publicly on the internet can be found by other WhatsApp users."

"The links that users wish to share privately with people they know and trust should not be posted on a publicly accessible website," Bonny told The Verge.

Danny Sullivan, Google's public search liaison, tweeted: "Search engines like Google & others list pages from the open web. That's what's happening here. It's no different than any case where a site allows URLs to be publicly listed. We do offer tools allowing sites to block content being listed in our results."

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.